search

Actoplus Met

PIOGLITAZONE HCL/METFORMIN HCL
*The product shipped may have different packaging depending on supplier/strength chosen

Actoplus Met

REQUIRED
PIOGLITAZONE HCL/METFORMIN HCL
Select Strength
BRAND
United Kingdom
Marketed as Competact in the United Kingdom Manufactured by: Takeda

Select Quantity
Other Actoplus Met Options for Purchase:
Type
Product
Manufacturer
Country
Qty-price (USD)

ActoPlus Met: Dual-Action Diabetes Management

Control Blood Sugar with a Powerful Combination

ActoPlus Met (pioglitazone/metformin) is a prescription medication designed to help individuals with type 2 diabetes manage their blood sugar levels more effectively. By combining two proven diabetes treatments, ActoPlus Met enhances insulin sensitivity while reducing glucose production, providing a comprehensive approach to diabetes care.

Improve Insulin Sensitivity and Reduce Glucose Production

This medication works by lowering blood sugar in two ways: pioglitazone helps the body use insulin more efficiently, while metformin decreases glucose production in the liver. Together, they help maintain stable blood sugar levels and improve long-term diabetes control.

Easy-to-Take Tablet for Daily Use

ActoPlus Met is taken as a simple oral tablet, making it convenient for daily diabetes management. When combined with a healthy diet and exercise, it helps patients achieve better glycemic control and reduces the risk of diabetes-related complications.